New diagnostic isotope to enhance targeted alpha therapy for cancer (IMAGE)
Caption
A multidisciplinary team of researchers have demonstrated production, purification, and potential for the 134Ce/134La in vivo generator as a PET imaging surrogate for 225Ac and 227Th radiotherapeutic agents
Credit
Los Alamos National Laboratory, Lawrence Berkeley National Laboratory, the University of California, and the University of Wisconsin
Usage Restrictions
None
License
Licensed content